Zoar Ltd

Exhibit 99.1 Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing, the combined company is expected to operate as Zoar Limited and trade on NYSE American under the ticker symbol “ZOAR…

425 · 2026-11-03 · 0001493152-26-049726

Exhibit 99.2 May 21, 2025 Board of Directors Impact Biomedical, Inc. 275 Wiregrass Pkwy Henrietta, NY 14586 Re: Fairness Opinion Members of the Board of Directors: This letter sets forth our opinion as to the fairness, from a financial point of view, to Impact Biomedical, Inc. (“Impact”), a publicly traded company, and, as a result, to its respective equity holders, of the proposed merger transaction with Dr. Ashleys Ltd (“Ashleys”). The terms of the transaction, as out…

F-4/A · 2026-10-22 · 0001493152-26-047960

Exhibit 99.1

F-4/A · 2026-10-05 · 0001493152-26-045654

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Limited (f/k/a Dr Ashleys Limited) Houston, Texas September 16, 2026 - Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. Securities and Exchange Commission (the “ SEC ”) on Thursday, September 10, 2026, by Zoar…

425 · 2026-09-17 · 0001493152-26-042978

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 CORRECTED - Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) Houston, Texas September 14, 2026 This corrected press release is being issued to correct the merger exchange ratio that was incorrectly stated in the press release of Impact Biomedical Inc. (the “Company” or “Impact”) dated September 11, 2026. The original press release incorrectly st…

425 · 2026-09-15 · 0001493152-26-042640

Calculation of Filing Fee Tables F-4 Zoar Ltd ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price …

F-4 · 2026-09-10 · 0001493152-26-042161